Stocks and Investing Stocks and Investing
Mon, March 9, 2020
Sun, March 8, 2020
Fri, March 6, 2020

Matt Miksic Maintained (BSX) at Buy with Decreased Target to $46 on, Mar 6th, 2020


Published on 2024-10-26 23:19:37 - WOPRAI, Matt Miksic
  Print publication without navigation


Matt Miksic of Credit Suisse, Maintained "Boston Scientific Corporation" (BSX) at Buy with Decreased Target from $51 to $46 on, Mar 6th, 2020.

Matt has made no other calls on BSX in the last 4 months.



There are 6 other peers that have a rating on BSX. Out of the 6 peers that are also analyzing BSX, 1 agrees with Matt's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Amit Hazan of "Goldman Sachs" Initiated at Hold and Held Target at $46 on, Thursday, February 13th, 2020


These are the ratings of the 5 analyists that currently disagree with Matt


  • Joshua Jennings of "Cowen & Co." Maintained at Buy with Increased Target to $52 on, Monday, December 30th, 2019
  • Robbie Marcus of "JP Morgan" Maintained at Buy with Increased Target to $55 on, Friday, December 20th, 2019
  • Mike Matson of "Needham" Downgraded at Strong Buy on, Thursday, December 19th, 2019
  • Cecilia Furlong of "Morgan Stanley" Maintained at Buy with Increased Target to $51 on, Tuesday, December 17th, 2019
  • Larry Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $52 on, Monday, December 16th, 2019

Contributing Sources